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ABSTRACT 
The vertebrate body is made by progressive addition of new tissue from progenitors at the 
posterior embryonic end. Axial extension involves different mechanisms that produce 
internal organs in the trunk but not in the tail. We show that Gdf11 signaling is a major 
coordinator of the trunk to tail transition. Without Gdf11 signaling the switch from trunk 
to tail is significantly delayed and its premature activation brings the hindlimbs and 
cloaca next to the forelimbs, leaving extremely short trunks. Gdf11 activity includes 
activation of Isl1 to promote formation of the hindlimbs and cloaca-associated mesoderm 
as the most posterior derivatives of lateral mesoderm progenitors. Gdf11 also coordinates 
reallocation of bipotent neuromesodermal progenitors from the anterior primitive streak 
to the tail bud, in part by reducing the retinoic acid available to the progenitors. Our 
findings provide a new perspective to understand the evolution of the vertebrate body 
plan. 
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INTRODUCTION 
Vertebrates display a large diversity of body shapes and sizes. Despite such 
morphological variations, their primary body axis is always generated from head to tail 
through a similar principle, consisting of the progressive addition of new tissue at the 
posterior end of the embryo (reviewed in Stern et al., 2006; Wilson et al., 2009). This 
process requires a fine balance between the maintenance of progenitor pools and the 
continuous production of cells that form the different body structures. Cells leaving the 
axial progenitor pools at different stages during the elongation process execute patterning 
and differentiation programs that are specific to each particular axial level. Quantitative 
and qualitative differences in these general processes are the basis of vertebrate body 
shape diversity. One of the most important components of anterior-posterior (AP) 
regional variation is the portion of the postcranial body occupied by the neck, trunk, and 
tail. For instance, the prototypical snake’s body has a very long trunk and rather short 
neck and tail. In contrast, birds exhibit long necks and reduced tails, whereas some 
lizards have fairly short necks and trunks, but very long tails. Thus, elucidating the 
mechanisms that control this regional organization is essential to understand the 
evolution of the vertebrate body plan. 
 The transition from trunk to tail is one of the key elements in AP organization of 
the vertebrate body. While the trunk holds most of the vital and reproductive organs, the 
tail is basically composed of vertebrae and its associated muscles. These differences 
reflect major changes in developmental mechanisms during axial extension. 
Embryologically, trunk tissues require extensive contributions from all three germ layers, 
including the lateral and intermediate mesoderm, which in concert with the endoderm 
originate the trunk-associated organs (Carlson, 1999). Conversely, tail tissues are mostly 
derived from the paraxial mesoderm and ectoderm. This means that the trunk to tail 
transition marks the posterior end of the endoderm, as well as of the lateral and 
intermediate mesoderm. Interestingly, this is associated with the induction of the 
hindlimb buds from the lateral mesoderm and with the activation of molecular programs 
in the ectoderm, hindgut endoderm, and ventral lateral mesoderm resulting in the 
production of the embryonic cloaca (Suzuki et al., 2009). The consequences of this 
embryological feature are still patent in the adult animal as the end of the trunk typically 
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correlates with the position of the cloaca and its derivatives, and of the hindlimbs, if the 
animal has them. 
 The trunk to tail transition is also associated with a switch in the mechanism 
guiding embryonic axial growth. Trunk formation is driven by a midline structure called 
the primitive streak (PS), in which ingressing cells from the epiblast generate the 
embryonic mesoderm and definitive endoderm (Psychoyos and Stern, 1996; Tam and 
Beddington, 1997; Wilson and Beddington, 1996). Conversely, caudal growth during tail 
formation is associated with the activity of the tail bud (Kanki and Ho, 1997; 
Schoenwolf, 1977). This change in the mode of axial growth involves the relocation of 
axial progenitors from the PS and adjacent areas of the epiblast to the caudal neural hinge 
(CNH) at the posterior end of the tail bud (Cambray and Wilson, 2002; 2007; Wilson and 
Beddington, 1996). 
 The mechanisms controlling the trunk to tail transition are largely unknown, 
despite their importance. As for other aspects of AP regional patterning, most of the 
studies on differences between the trunk and the tail have focused on their associated 
skeleton (reviewed by Mallo et al., 2009; 2010; Wellik, 2007). In the adult animal, the 
trunk typically expands through the thoracic and lumbar segments of the vertebral 
column, whereas the transition to the tail occurs through the sacrum and the tail itself is 
associated with caudal vertebrae. Regional specification of these skeletal segments results 
from the execution of distinct patterning programs during differentiation of the somitic 
mesoderm (reviewed by Mallo et al., 2009; 2010; Wellik, 2007). Although coordinated 
with the networks controlling other aspects of trunk and tail development, these 
mechanisms mostly operate within the paraxial mesoderm and cannot account for such 
transition. Indeed, a variety of genetic experiments in the mouse indicate that the embryo 
can undergo major patterning changes in their axial skeletons with very little or no 
obvious effects on hallmarks of the trunk to tail transition, such as the position of the 
hindlimbs (Carapuço et al., 2005; McIntyre et al., 2007; Vinagre et al., 2010; Wellik and 
Capecchi, 2003). There are a few mutant phenotypes, however, that are suggestive of a 
simultaneous alteration in several aspects of the trunk to tail transition. Those associated 
with the inactivation of Gdf11 signaling in mice are particularly interesting, as they 
produce a global anteriorization of the axial skeleton (Andersson et al., 2006; Essalmani 
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et al., 2008; McPherron et al., 1999; Oh et al., 2002; Szumska et al., 2008). Mutants for 
members of this pathway generally present 16-18 thoracic and 7-8 lumbar segments 
instead of the wild type 13 and 6 vertebrae, respectively. In these mutants, 
transformations in the axial skeleton are associated with a posterior displacement of the 
hindlimbs by about 6-8 vertebral units (Andersson et al., 2006; McPherron et al., 1999; 
Oh et al., 2002; Szumska et al., 2008). 
 Here, we show that Gdf11 signaling is a major regulator of the trunk to tail 
transition during vertebrate development. Whereas loss of Gdf11 delays the specification 
of the cloaca and the induction of the hindlimbs, precocious activation of Gdf11 signaling 
in the epiblast using a constitutively active form of its receptor, Alk5CA, produces a 
remarkable anteriorization of these structures, with a concomitant reduction in trunk 
length. Strikingly, by using different promoters, we show that this activity is required in 
the axial progenitors of the epiblast and not in the derived mesoderm. We present 
evidence that the switch from trunk to tail progenitors requires a combination of several 
processes. These include activation of Isl1 in the progenitors for the lateral mesoderm, 
which results in the induction of the hindlimb buds and cloacal tissues. The regulation of 
Isl1 expression by Gdf11 signaling seems to be mediated by direct control of a relevant 
enhancer of Isl1 that is specifically active during this transition. Gdf11 signaling is also 
involved in the orderly relocation of the bipotent neuromesodermal (N-M) progenitors 
from the PS to the tail bud, a process that requires inactivation of retinoic acid signaling. 
 
RESULTS	  
Loss of Gdf11 delays trunk to tail transition in mice 
Gdf11 mutant newborn animals present anterior homeotic transformations along the axial 
skeleton, with posterior displacement of the hindlimbs by 6 to 8 vertebrae (McPherron et 
al., 1999). Analysis of these mutants at embryonic day (E)11.5 revealed that the hindlimb 
buds were indeed more posteriorly located, producing an increased interlimb (trunk) 
region by 5 or 6 somites when compared to wild type embryos (Fig. 1A,B). At this stage, 
Gdf11 mutant hindlimbs were visibly smaller than those of their wild type littermates 
(Fig. 1A,B), which contrasted with their normal morphology at E18.5 (Fig. S1A,B). 
Embryonic staging based on hindlimb morphology (Boehm et al., 2011) revealed that the 
	   6	  
hindlimbs of E10.5 and E11.5 Gdf11 mutant embryos corresponded to those of younger 
wild type embryos by about 6 and 17 hours, respectively (Fig. 1C). This observation 
raised the possibility that hindlimb specification is delayed in Gdf11 mutant embryos. 
Consistent with this hypothesis, analysis of Tbx4 expression, an early hindlimb marker 
(Gibson-Brown et al., 1996), revealed that the hindlimb fields were first identified at an 
axial level 5-6 somites more posterior in Gdf11 mutants than in wild type embryos (Fig. 
1D,E). These results suggest that Gdf11 is involved in establishing the position at which 
the hindlimb is induced along the AP axis. 
 Given the correlation between the hindlimbs and the trunk to tail transition, the 
above results suggest that Gdf11 signaling plays a fundamental role in setting this 
transition. Consistent with this, other hallmarks of the trunk to tail transition were also 
posteriorly displaced in Gdf11 mutants, compared with wild type littermates. In 
particular, we examined both endodermal (Shh and Fgf8 expression) (Fig. 1F-I) and 
mesodermal (Isl1 and Raldh2 expression) (Figs 1J,K and S1C-F) components of the 
developing cloaca. In Gdf11 mutants, these markers were expressed next to the posterior 
end of the hindlimb buds, similar to what was observed in wild type embryos, revealing 
that the primordium of the cloaca was also located at a more posterior absolute axial 
level. In addition to the posterior displacement of the hindlimb buds and the cloaca, 
formation of other tissues and structures typically associated with the trunk was caudally 
extended in Gdf11 mutant embryos. For instance, expression of Pax2 and Raldh2 
revealed a posterior elongation of the intermediate mesoderm, which is the precursor of 
the urogenital tract (Figs 1L,M and S1C,D). Similarly, the visceral lateral mesoderm 
extended to more caudal levels, as evidenced by the expression of Wnt2 (Fig. 1N,O). 
Altogether, these results show that the trunk to tail transition was posteriorly displaced in 
Gdf11 mutants and that this was associated with a concomitant extension of trunk-
associated tissues to cover the body up to the cloacal level. They also indicate that the 
alterations observed in the axial skeleton of these mutants (McPherron et al., 1999) are 
just one manifestation of a more global deregulation of AP patterning processes. 
 
	   7	  
Alk5 activation in the epiblast anteriorizes the trunk to tail transition 
To explore whether Gdf11 signaling is able to dominantly control the trunk to tail 
transition, we took a gain of function approach in mouse embryos. Genetic and 
biochemical experiments revealed that Gdf11 first binds Acvr2b to form a complex that 
then activates Alk5 (also known as Tgfbr1) to initiate a signaling cascade mediated by 
Smad2 (Andersson et al., 2006; Ho et al., 2010; Liu, 2006; Oh et al., 2002). It has been 
suggested that the start of Gdf11 functional activity is determined by Alk5 availability, 
which in axial tissues seems to start at around E9.0 (Andersson et al., 2006). Therefore, 
for our gain of function experiments we produced transgenic embryos expressing a 
constitutively active version of Alk5 (Alk5CA), which signals independently of the ligand 
(Wieser et al., 1995). 
 We first expressed Alk5CA using an enhancer element of the Cdx2 gene (Cdx2P-
Alk5CA transgenics), which has been shown to drive expression in the posterior epiblast 
and PS (Benahmed et al., 2008; Gaunt et al., 2005). Activity of this enhancer was 
detected in the progenitors for neural and mesodermal tissues posterior to the forelimb 
bud level, although the forelimb progenitors were themselves mostly not targeted by the 
enhancer (Fig. S2A-C). Cdx2P-Alk5CA embryos exhibited strong phenotypes affecting 
posterior embryonic growth (n=22 out of 37 transgenics), which could be classified in 
two groups. The most severe phenotypes (n=12) included a drastic axial truncation 
leaving very little tissue posterior to the forelimbs (Fig. S2D,E). This phenotype did not 
permit the analysis of patterning processes in the trunk region of these embryos. Another 
group of Cdx2P-Alk5CA embryos (n=10), however, exhibited milder phenotypes, 
extending their AP axis beyond the forelimb bud level. These embryos had short bodies 
but contained clearly recognizable hindlimbs and tails, and preserved fairly normal 
overall regional organization (Fig. 2). Interestingly, their hindlimbs were located very 
close to the forelimbs, leaving extremely short trunks spanning 0-6 misshapen somites in 
contrast to the typical 12-13 somites observed in wild type E10.5 embryos. The position 
of the anteriorized hindlimbs was often asymmetric and in one transgenic embryo the 
hindlimb buds were duplicated (Fig. 2L). In these embryos the cloaca also developed in a 
more anterior location, maintaining its relative anatomical position with respect to the 
hindlimbs (Fig. 2E-H). Globally, these phenotypes were essentially the opposite to those 
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observed in Gdf11 mutant embryos, thus reinforcing the important role of Gdf11/Alk5 
signaling in establishing the position of the trunk to tail transition. We were not able to 
recover any affected Cdx2P-Alk5CA transgenic at a stage that allowed direct evaluation of 
AP patterns in the axial skeleton. However, the anterior expression boundaries of Hoxa9 
and Hoxc10 at E10.5 were anteriorized, maintaining their position relative to the 
hindlimb bud (Fig. 2I-L), indicating altered AP patterns also in the paraxial mesoderm 
and neural tube. This observation is consistent with previous Gdf11 gain of function 
experiments in chicken embryos (Liu, 2006). Altogether, these results indicate the 
existence of a global and coordinated posteriorization of the body plan of Cdx2P-Alk5CA 
transgenic embryos that involves tissues from all germ layers. 
 It has been reported that the Cdx2 enhancer used in these experiments is active in 
both the axial progenitor-containing posterior epiblast and in the underlying mesodermal 
compartments (Benahmed et al., 2008). To evaluate if the phenotypes observed in the 
Cdx2P-Alk5CA transgenics derived from Alk5 activity in the epiblast or in the 
mesodermal compartments, we overexpressed Alk5CA in the paraxial mesoderm using the 
Dll1-msd enhancer (Beckers et al., 2000) and in the lateral mesoderm using a Hoxb6 
enhancer (Becker et al., 1996). We could not identify any abnormality in any of these 
transgenics (n=21 and n=22, respectively), indicating that the phenotypes observed in 
Cdx2P-Alk5CA transgenics are most probably derived from the activation of Alk5 
signaling in the epiblast and not in the derived mesodermal compartments. 
 Taken together, our results indicate that Gdf11/Alk5 signaling is a key modulator 
of the transition from trunk to tail in the mouse. In addition, they show that this signaling 
is required in the epiblast and it is therefore very probable that it primarily acts on the 
axial progenitors. This suggests that Gdf11 signaling might be involved in the modulation 
of the different functional changes in these progenitors driving their switch from making 
trunk to tail tissues. 
 
Altered tail bud organization in Gdf11 mutant embryos 
A typical characteristic of Gdf11 mutant skeletons is their truncation at the sacral/caudal 
level (McPherron et al., 1999). In midgestation embryos, we found that the tails of Gdf11 
mutant embryos exhibited variable phenotypes, typically being distally thinner than in 
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wild type embryos and duplicated in a proportion of them (Fig. S3A,D). T (Brachyury) 
was expressed at the tip of both tail tips (Fig. S3D), indicating that the duplicated tail 
might have resulted from a splitting of the posterior organizing area. Therefore, we 
investigated the transition from PS to tail bud in Gdf11 mutant embryos. At E9.5 we 
already observed deviations from the normal T expression pattern in Gdf11-/- embryos, as 
transcripts for this gene were distributed in a broader domain that extended anteriorly 
through the prospective tail tip (Fig. 3A,B). This broadening was progressively resolved 
into a distinct domain, which appeared to segregate by E10.5 (Fig. 3C,D). In these 
embryos, distal thinning of the tail bud started to become evident. At this stage, 
expression of other genes functionally associated with the posterior growth area at the tail 
tip, like Cdx2, Fgf8, and Wnt3a, also exhibited abnormal expression to different extents 
(Fig. 3I-N). At E11.5 we could observe two or three distinct T-positive domains along the 
ventral side of the tails of Gdf11 mutants, from their tip to the posterior border of the 
hindlimb buds, even in embryos without split tails (Fig. 3E,F). However, at this stage, 
expression of the other markers was restricted to the posterior end of the tail or present at 
differential levels in the two tail tips when the embryos had a split tail (Figs 1I and S3E-
H). Interestingly, in all Gdf11-/- embryos analyzed at E11.5 we found an ectopic T-
expression domain located next to the hindlimbs, regardless of whether or not their tails 
were split (Figs 3F and S3D). This group of cells was negative for other tested markers of 
the posterior organizing area (Fig. S3F,H). Surprisingly, although these cells were 
positive for T, we could not identify ectopic formation of mesodermal tissues in the 
caudal end of the Gdf11 mutants. Instead, we observed ectopic neural tissue ventrally 
located outside the vertebral column (Fig. S3I,J), an observation consistent with previous 
analysis of both Gdf11 and Pcsk5 mutant embryos (Szumska et al., 2008). It has been 
established that the bipotent N-M progenitors in the tail bud take a neural fate in the 
absence of Wnt3a activity (Martin and Kimelman, 2012). Therefore, it is possible that the 
ectopic T domain represents a fraction of such progenitors that failed to become 
incorporated into the CNH and differentiated into neural tissue due to the absence of 
Wnt3a. 
 Altogether, these results are consistent with an abnormal PS to CNH transition in 
the absence of Gdf11 activity, in which the pool of axial progenitors normally fated to 
	   10	  
form the CNH becomes split into several domains instead of a single region at the tail tip. 
The split tail might be produced when the number (or specific characteristics) of 
progenitors trapped halfway through the tail is large enough to generate another tail bud, 
eventually creating a secondary ventral tail. 
 
Gdf11 is required to reduce RA levels during the transition from PS to CNH 
It has been reported that the tail truncation of Gdf11-/- fetuses can be partially rescued by 
pharmacological inhibition of retinoic acid (RA) signaling (Lee et al., 2010). The timing 
of the effective treatment fits with the PS to CNH transition, which raises the possibility 
that the tail rescue may result from the recovery of this process. To test this possibility, 
we analyzed how treatment with the RA inhibitor AGN193109 affected tail bud 
development in Gdf11 mutants. Notwithstanding some degree of variability (probably 
resulting from different efficiencies of the treatment), the tails of these embryos at E10.5 
were consistently longer and thicker than those of untreated Gdf11-/- embryos, some of 
them resembling the tails of wild type embryos (Fig. 3G). In addition, we did not find any 
embryo with a split tail. T expression in the caudal end of these embryos also showed 
some variability but in most embryos it was restricted to the tail tip without ectopic T-
expressing domains (Fig. 3G). These results indicate that inhibition of RA signaling 
produces a significant reversion of the abnormalities observed in the PS to CNH 
transition typically observed in Gdf11 mutants, placing RA signaling as a key element 
causing the abnormal behavior of axial progenitors in Gdf11 mutant embryos. 
 To further explore this hypothesis, we performed the complementary experiment 
and analyzed the effect of increased RA levels at the time of the PS to CNH transition on 
the axial progenitors of Gdf11-/- embryos. At E11.5, RA-treated mutants had variable tail 
malformations that were always stronger than those observed in non-treated Gdf11 
mutant embryos (Fig. 3H). Tail morphologies varied from hair-like shapes to the 
complete absence of the tail posterior to the hindlimbs, which fit with the stronger 
skeletal truncations described for Gdf11 mutants after similar treatments (Lee et al., 
2010). T expression in the posterior part of these embryos was mostly restricted to the 
ectopic ventral domain, while expression in the remaining tail tip was severely reduced 
(Fig. 3H). It should be noted that, although wild type embryos can be similarly truncated 
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upon RA exposure, they require about 10 times higher concentrations of the drug for an 
equivalent effect (Kessel, 1992). This indicates that Gdf11 mutants exhibit an increased 
sensitivity to RA. The effects that exogenous modulation of RA signaling has on the axial 
progenitors of Gdf11 mutants are consistent with the idea that the distribution of 
progenitors between the tail tip and the ectopic domains depends on RA signaling. 
Furthermore, these effects suggest that appropriate PS to CNH transition requires 
complete block of RA signaling in these progenitors. These results reinforce the 
interpretation that the truncated tail phenotypes observed in Gdf11 mutants are, at least to 
some extent, the result of a failure to undergo proper PS to CNH transition. 
 Because the strength of the Gdf11-/- axial progenitor phenotype can be altered by 
exogenous modulation of RA levels, it is probable that Gdf11 signaling is required to 
adjust the amount of available RA at the posterior embryonic end. Considering the 
essential role of Cyp26a1 in RA degradation (Abu-Abed et al., 2001; Sakai et al., 2001), 
a possible mechanism for RA signaling control by Gdf11 activity is to regulate the 
expression levels of Cyp26a1 during the trunk to tail transition. Consistent with this, 
Cyp26a1 expression levels were reduced in the posterior end of Gdf11 mutant embryos at 
the time of the PS to CNH transition (Fig. 3O,P). This could be the origin of an uneven 
RA distribution along the AP axis, which would eventually result in different pools of 
progenitors being exposed to RA levels above or below a critical threshold when they are 
about to undergo PS to CNH relocation. 
 
Hox genes do not play a major role in establishing the AP position of the hindlimb 
The above results show that RA plays a role in Gdf11 function controlling the PS to CNH 
transition. However, inhibition of RA signaling had no or only minor effects on other 
aspects of the Gdf11 mutant phenotype, including the axial formula and the hindlimb 
position (data not shown) (Lee et al., 2010). This indicates that Gdf11 signaling controls 
the axial position of the trunk to tail transition and the proper formation of the CNH 
through different mechanisms. 
 The alterations in the axial formula can be explained by abnormal Hox gene 
expression in the paraxial mesoderm (Fig. S4) (McPherron et al., 1999; Szumska et al., 
2008). It is not clear, however, how Gdf11 signaling controls the changes related to the 
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lateral mesoderm during trunk to tail transition that lead to the induction of structures 
such as the hindlimb buds. Analysis of Hoxa9 and Hoxc10 expression in both Gdf11 
mutant and Cdx2P-Alk5CA transgenic embryos showed that their activation followed the 
altered position of the hindlimbs (Figs 2I-L and S4), suggesting that Hox genes could 
control AP patterning in the lateral mesoderm during the trunk to tail transition. A few 
mutant phenotypes including genes of the Hox9, Hox10 and Hox11 groups have been 
reported to include a slight posterior displacement of their hindlimbs (Favier et al., 1996; 
McIntyre et al., 2007), but they seem too mild to support a major role for Hox genes in 
this process. To understand if the absence of stronger phenotypes resulted from 
functional redundancies (as observed for other Hox-dependent processes) we took a gain 
of function approach by precociously expressing the Hox genes of these paralogs in 
transgenic embryos. Only transgenics expressing a gene of the Hox9 group (Hoxb9) in 
the epiblast showed a slight anterior displacement of the hindlimbs by one segmental unit 
(1 somite at E10.5, which was translated into 5 instead of 6 lumbar vertebra at E18.5) 
(Fig. 4). However, no obvious alterations in the hindlimb position were detected when 
Hoxa10, Hoxc10, or Hoxa11 were used in similar experiments (Table S1). Also, 
combined expression of different Hox genes did not change the phenotypes obtained with 
individual Hox genes (Table S1). Therefore, the results from both gain and loss of 
function approaches are not supportive of a major role of Hox genes in specifying the 
hindlimb position along the AP axis during trunk to tail transition. 
 
Isl1 organizes the terminal differentiation of lateral mesoderm progenitors during 
trunk to tail transition 
Given the relatively minor effect of Hox genes on positioning the hindlimb, we 
investigated other factors that could mediate hindlimb induction by Gdf11 during the 
trunk to tail transition. We noticed that both Hand2 and Shh expression in the hindlimbs 
of Cdx2P-Alk5CA transgenics was not restricted to the posterior mesenchyme, but 
extended into more anterior areas of the hindlimb bud (Figs 2A,B and 5A,B). Isl1 has 
been shown to control a Shh/Hand2 network associated with hindlimb induction (Itou et 
al., 2012). This observation, together with cell tracing studies showing that this gene is 
specifically activated in the lateral mesoderm associated with the hindlimb and ventral 
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lateral mesoderm (Yang et al., 2006), in addition to genetic experiments indicating that it 
is involved in early stages of hindlimb induction (Kawakami et al., 2011; Itou et al., 
2012), suggest a possible role for Isl1 in patterning the lateral mesoderm during trunk to 
tail transition downstream of Gdf11 signaling. To test this possibility we first expressed 
this gene using the Cdx2P enhancer in transgenic embryos (Cdx2P-Isl1 transgenics). 
Although the observed phenotypes varied in intensity, these transgenics typically 
exhibited a more anterior position of the hindlimbs (Fig. 5C-F), which at E10.5 could 
reach a position up to 6 somites away from the forelimb buds. In contrast to what we 
observed in Cdx2P-Alk5CA transgenics, the anteriorized position of the hindlimbs in 
Cdx2P-Isl1 transgenics was associated with a truncation of the tail bud already evident at 
E10.5 (strong phenotypes were observed in 8 out of 15 transgenics at this stage) (Fig. 5E-
H). At E18.5, this was reflected in the complete truncation after the 8th thoracic vertebra 
affecting both the axial skeleton and the neural tube (Fig. 5I,J,N). However, these fetuses 
had hindlimbs with strikingly normal skeletal morphology, which were “floating” within 
the soft tissue adjacent to the caudal end of the truncated axial skeleton (Fig. 5J). In 
addition, the digestive and excretory systems of Cdx2P-Isl1 transgenics had an organized 
opening to the exterior (Fig. 5K,L), although the urethra and rectum shared a common 
end (Fig. 5L,M). They also had recognizable external genitalia (Fig. 5K,L) and fully 
developed kidneys (Fig. 5O). In contrast, we could not identify any sign of the gonads. 
These results indicate that the structures derived from the areas that are normally 
associated with Isl1-positive tissues (e.g. the most caudal parts of the lateral and of the 
intermediate mesoderm) were largely not affected by the precocious activation of Isl1 in 
the epiblast. Areas that are normally not in contact with Isl1 activity, however, like the 
paraxial mesoderm, neural tube, and more anterior areas of the intermediate mesoderm 
(e.g. those forming the gonads) were strongly affected by expression of Isl1. 
 Contrary to Cdx2P-Isl1 transgenics, embryos expressing Isl1 in the paraxial 
(Dll1-Isl1 transgenics, n=13) or the lateral (Hoxb6P-Isl1 transgenics, n=11) mesoderm 
were indistinguishable from their wild type littermates at E10.5. This indicated that, 
similar to Gdf11/Alk5 signaling, Isl1 may affect mesodermal AP patterning when 
activated in the axial progenitors of the epiblast but not in the mesodermal tissues after 
their ingression through the PS. Given that Isl1 expression is associated with the 
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induction of the most posterior derivatives of the lateral mesoderm, we hypothesized that 
this gene might trigger the terminal differentiation of the trunk progenitors. In the 
progenitors for the lateral mesoderm this would be associated with specific physiological 
programs (like those resulting in hindlimb induction), but in axial progenitors for tissues 
normally not in contact with Isl1 activity, it would simply result in their depletion. To test 
if this could indeed be the case, we analyzed T expression in Cdx2P-Isl1 transgenics at 
E10.5. We found that in these embryos T was still expressed in the notochord associated 
with the anterior part of the embryo. However, it was almost completely absent from the 
tail bud (Fig. 5G,H). This is consistent with the idea of a loss of progenitors forming 
neural and paraxial mesodermal structures of the tail bud. Altogether, these data support 
the incompatibility between Isl1 expression and the maintenance of axial progenitors and 
suggest a developmental role for Isl1 in the programmed termination of the lateral 
mesoderm progenitors as part of the trunk to tail transition. 
 The observation that Isl1 and Gdf11 signaling are both required in the axial 
progenitors to modulate AP patterning of the lateral mesoderm led us to explore if Isl1 is 
a direct target of Gdf11/Alk5 signaling. Kang et al. (2009) have recently characterized 
enhancer elements involved in the activation the Isl1 gene in the cardiac progenitors and 
in the posterior part of the embryo. We found several putative Smad2 binding sites within 
one of the most conserved regions of this enhancer (CR2 in Kang et al., 2009) (Fig. 
6A,B), suggesting that Isl1 could be a target of the Gdf11 pathway. In transgenic 
embryos, CR2 was able to drive expression of a reporter gene specifically in the caudal 
end of the lateral mesoderm (Fig. 6D), thus mimicking the normal expression domain of 
Isl1 in this area (Fig. 6C) (Yang et al., 2006). Inactivation of all potential Smad sites in 
this enhancer rendered it inactive (Fig. 6E), indicating that they are required for enhancer 
activity. Taken together, our results identify Isl1 as a direct physiological target of Gdf11 
in its activity to modulate the trunk to tail transition during mouse axial elongation. 
 
DISCUSSION 
In this work, we have shown that Gdf11 is a central modulator of the processes involved 
in the trunk to tail transition in the mouse embryo. This is supported by both loss and gain 
of function experiments. In Gdf11 mutant embryos the trunk to tail transition (which can 
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be conveniently identified by the position of the hindlimb and cloaca-related tissues) was 
posteriorly displaced, leading to the formation of a longer trunk. Conversely, precocious 
activation of Gdf11 signaling using a constitutively activated form of its receptor Alk5 
produced a strong anterior displacement in the hindlimb position, which resulted in 
dramatically shortened trunks. It should be noted that although delayed, the trunk to tail 
transition still occurs in Gdf11 mutant embryos. One possible explanation is that Gdf11 
activity is partially compensated by other molecules that activate the same signaling 
pathway. A candidate for such molecule is Gdf8 (Myostatin) as inactivation of this gene 
intensifies the Gdf11 mutant phenotype in the axial skeleton (McPherron et al., 2009). An 
analysis of the trunk to tail transition in Gdf11/Gdf8 double mutants has not been 
reported. However, the longer rib cages observed in these embryos, together with the 
more anterior axial truncation at the lumbar level, and the presence of strongly reduced 
hindlimbs (McPherron et al., 2009) are compatible with a largely incomplete or absent 
trunk to tail transition. Alternatively (or in addition), other signaling pathways can act in 
parallel during this process, protecting Gdf11 mutant embryos from a complete block in 
the switch from making trunk to tail tissues. 
 
The hindlimb and ventral lateral mesoderm as a product of terminal differentiation 
of the lateral mesoderm progenitors 
During the trunk to tail transition the axial progenitors relocate from a position in the PS 
and adjacent epiblast to the CNH (Cambray and Wilson, 2002; 2007; Wilson and 
Beddington, 1996). This relocation does not include all progenitors. In particular, those 
for the lateral and intermediate mesoderm, involved in the genesis of the trunk associated 
organs, are not incorporated into the CNH. Instead, specific differentiation programs are 
activated in these progenitors to generate the hindlimbs and the ventral lateral mesoderm, 
which interacts with the hindgut endoderm to organize the posterior end of several trunk 
associated organ systems. Indeed, even in some snakes, a small hindlimb primordium is 
produced in this position that later fails to produce a full grown member (Cohn and 
Tickle, 1999). Gdf11 signaling seems to play a role in this process through a mechanism 
that includes activation of Isl1 in the progenitors for the lateral mesoderm. This is in 
agreement with lineage tracing experiments showing that in wild type embryos, Isl1 
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becomes specifically activated in the progenitors of the hindlimb and ventral lateral 
mesoderm (Yang et al., 2006). It is also consistent with genetic experiments showing that 
hindlimbs are not formed in the absence of this gene (Kawakami et al., 2011; Itou et al., 
2012). In addition, we showed here that precocious activation of Isl1 in axial progenitors 
of the epiblast was able to induce the hindlimbs and cloacal tissues at more anterior axial 
levels, thus mimicking to some extent the Cdx2P-Alk5CA phenotypes (see below). 
Importantly, a conserved enhancer for the Isl1 gene that activates expression in the most 
caudal part of the lateral mesoderm, contains several Smad binding sites that are essential 
for its activity, thus establishing a direct connection between Gdf11 signaling and Isl1 
activation. In this context, it should be noted that activation of this enhancer requires 
other factors in addition to Gdf11 signaling. Indeed, this regulatory element is inactive in 
the progenitors for the neural tube or paraxial mesoderm, although Gdf11 signaling is 
active in this area. Fox genes are among the best candidates to cooperate with Gdf11 
signaling in activating this enhancer because it also contains Forkhead binding sites that 
are essential for enhancer activity (Kang et al., 2009). FoxF1 is one of the prime 
candidates to play a physiological role in this process for its expression is detected in the 
lateral mesoderm but not in the neural tube and paraxial mesoderm (Mahlapuu et al., 
2001). 
 One of the most striking characteristics of the Cdx2P-Isl1 transgenics was the 
totally different effects that Isl1 expression had on the various axial progenitors. In the 
progenitors of the lateral mesoderm, precocious Isl1 activation had surprisingly little 
effect on the morphogenesis of the posterior lateral mesoderm derivatives, other than 
their induction at a more anterior axial level. However, Isl1 activation had strong 
deleterious effects on the progenitors of more medial tissues, like the notochord, the 
neural tube, and paraxial mesoderm, which normally do not express Isl1. Therefore, the 
phenotype that we observed in the Cdx2P-Isl1 transgenics might indicate that Isl1 activity 
has negative effects on progenitor maintenance, bringing them into terminal 
differentiation pathways. In the progenitors of the lateral mesoderm, the cessation of 
progenitor renewal is combined with activation of the genetic programs resulting in the 
formation of structures like the hindlimb or the ventral lateral mesoderm. From this 
perspective, the hindlimb and cloacal tissues could represent the product of terminal 
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differentiation of the progenitors for the lateral mesoderm associated with the trunk to tail 
transition. In Cdx2P-Isl1 transgenics, most axial progenitors are prematurely exposed to 
Isl1. In the progenitors for the lateral mesoderm, this triggered the physiological program 
at an earlier developmental stage. However, activation of Isl1 in the precursors of neural 
tube and paraxial mesoderm led to a block in progenitor maintenance that was not 
associated with an organized differentiation program, thus producing the morphological 
truncation of axial structures. 
 It should be noted that we never found Cdx2P-Isl1 transgenics with hindlimbs 
closer than 6 somites to the forelimb buds or with axial truncations anterior to the 8th 
thoracic segment, indicating that the competence of the axial progenitors to respond to 
Isl1 is not uniform along the AP axis. Considering that Alk5 can induce hindlimb buds at 
more anterior levels than Isl1 when prematurely activated in the epiblast, it is probable 
that the competence of the axial progenitors to respond to Isl1 is also provided by Gdf11. 
Whether this is indeed the case as well as the mechanisms mediating this gain of 
competence remains to be determined. 
 Intriguingly, the skeletal phenotype that we observed in Cdx2P-Isl1 transgenics is 
remarkably similar to the clinical characteristics found in patients with severe cases of 
spinal segmental dysgenesis (Mahomed and Naidoo, 2009), which raises the possibility 
that deregulation of Isl1 expression during trunk to tail transition could be in the origin of 
this human syndrome. 
 
Setting the PS to CNH transition 
Another of the major processes associated with the trunk to tail transition is the relocation 
of the N-M progenitors from the anterior PS and adjacent epiblast to the CNH to form the 
tail bud (Cambray and Wilson, 2002; 2007; Wilson and Beddington, 1996). Our results 
indicate that Gdf11 signaling is also involved in this process and that this activity is 
mediated by modulation of RA availability at the posterior embryonic end. In addition, 
our data suggest that proper PS to CNH transition requires a complete block of RA 
signaling because its pharmacological inhibition produced a significant recovery of the 
PS to CNH reorganization in Gdf11-/- embryos. This is consistent with the phenotype of 
Cyp26a1 mutant embryos (Abu-Abed et al., 2001; 2003; Sakai et al., 2001). Indeed, it has 
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been shown that in the absence of this RA-catabolyzing enzyme, embryos are exposed to 
an excess of RA that produces axial truncations at the lumbo-sacral level, which 
coincides with the stage when the PS to tail bud transition is taking place. The expression 
patterns reported for markers like T or Cdx4 in Cyp26a1 mutant embryos are compatible 
with strong alterations in the PS to tail bud transition (Abu-Abed et al., 2003). Our data 
also suggest that Gdf11 signaling modulates RA availability by regulating Cyp26a1 
expression. Accordingly, Cyp26a1 levels were lower in Gdf11 mutants than in wild type 
embryos during trunk to tail transition. Interestingly, the observation that Cyp26a1 
expression was reduced but not completely inactivated in Gdf11 mutants at this 
developmental stage may explain the segregation of the axial progenitors into several 
domains. In particular, progenitors closer to the tail tip would be surrounded by sufficient 
Cyp26a1 to protect them from RA. However, the levels of Cyp26a1 in more anterior 
areas would fall below the threshold level required for effective RA clearance, leaving 
progenitors in this area exposed to RA. A reduction in Cyp26a1 expression in the tail of 
Gdf11 mutants has been previously reported at later developmental stages, associated 
with other developmental processes (Lee et al., 2010), further reinforcing the connection 
between Gdf11 signaling and the RA catabolic pathway. 
 The apparent separation between RA-responding and RA-non-responding 
progenitors observed in Gdf11 mutants suggest that the PS to CNH transition might 
require activation of stage-specific characteristics in the axial progenitors (e.g. adhesion 
properties) that would target them to specific regions (a progenitor niche?) of the 
posterior embryonic end, eventually generating a tail-bud primordium that organizes 
posterior embryonic growth. According to this hypothesis, acquisition of those properties 
would require complete down regulation of RA signaling in these progenitors. Activated 
RA signaling during the PS to CNH transition would impair colonization of the tail bud 
primordium niche. When the majority of progenitors respond to RA (like Cyp26a1 
mutants, Gdf11 mutants treated with low doses of RA, or wild type embryos treated with 
high RA doses), the tail bud does not form and severe axial truncations occur at the level 
of the trunk to tail transition (Abu-Abed et al., 2001; 2003; Kessel, 1992; Sakai et al., 
2001; Lee et al., 2010). 
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EXPERIMENTAL PROCEDURES 
 
Transgenic constructs, mice and embryos 
The Gdf11 mutant strain used in this work has been described previously (McPherron et 
al., 1999). The constructs for the production of transgenic embryos were generated using 
standard molecular cloning techniques. The enhancers used for these constructs were a 
9.5 kb fragment upstream of the Cdx2 gene (Cdx2P) (Benahmed et al., 2008), the msd 
enhancer of the Dll1 gene (Beckers et al., 2000), and the lateral mesoderm enhancer of 
the Hoxb6 gene (Becker et al., 1996). The Isl1 CR2 enhancer (Kang et al., 2009) was 
amplified by PCR from mouse genomic DNA using primers 5’-
TCCTCACACTGGTCTAACCAG-3’ and 5’-GGACATCCCCACCCAGCGCTG-3’. To 
produce an enhancer without Smad binding sites, the different Smad targets were 
modified to CACA, except for the palindromic target GTCTAGAC that was changed to 
CATGCAGG. All these modifications were performed using a PCR-based mutagenesis 
strategy and verified by direct sequencing. The wild type and mutant Isl1 enhancers were 
cloned upstream of the adenovirus2 minimal late promoter and the resulting regulatory 
elements were inserted upstream the β-galactosidase cDNA. The Isl1 cDNA was IMAGE 
clone 40130540. To produce the Alk5CA cDNA, we used IMAGE clone 7098473, 
corresponding to the rat gene, and changed the threonine 204 for an aspartic acid (Wieser 
et al. 1995) using a PCR-based mutagenesis strategy. The mutation was confirmed by 
direct sequencing of the cDNA clones. The Cdx2P-creERT construct contained a 
tamoxifen-inducible cre recombinase (Hayashi and McMahon, 2002). All transgenic 
constructs contained the SV40 polyadenylation signal in addition to the regulatory 
regions and relevant cDNAs. 
 Transgenic embryos were generated by pronuclear injection of the relevant 
constructs according to standard methods (Hogan et al., 1994). Gdf11 mutant embryos 
were obtained from Gdf11+/- intercrosses. The day that plugs were found was considered 
E0.5. In the case of transgenic embryos, E0.5 was the day after the transfer of injected 
oocytes. The activity of the Cdx2P enhancer was estimated by crossing Cdx2P-creERT 
transgenics with the ROSA26R reporter line (Soriano, 1999) and pregnant females were 
treated with 4 mg of tamoxifen/20 g of body weight, dissolved in corn oil by 
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intraperitoneal injection. Embryos were collected from pregnant females by cesarean 
section and fixed with 4% paraformaldehyde (PFA) in PBS for in situ studies or with 
Mirsky's fixative (National Diagnostics) for β-galactosidase staining. 
 Treatment with RA and RA inhibitor were performed as in Lee et al., (2010) with 
slight modifications. Briefly, the stock solution of RA inhibitor AGN193109 (1 mg/ml in 
DMSO) was dissolved in corn oil and administered to pregnant females in three doses of 
2 mg/kg of body weight between E7.5 and E9.5. For RA treatments, a 25 mg/ml solution 
of all-trans RA in DMSO was diluted in corn oil and was administered at E8.5 by oral 
gavage at a final concentration of 10 mg/kg of body weight.  
 
Phenotypic analyses and statistics 
Comparison of hindlimb development between wild type and Gdf11 mutant embryos was 
performed using the morphometric system developed by Boehm et al. (2011). Results 
were presented as mean ± SEM and compared using the Student's t test (p<0.05 was 
considered significant). To see the external morphology of midgestation embryos in 
greater detail, they were stained in hydrochloric carmine using a modified protocol from 
Machado-Silva et al. (1998) (see supplementary information for details). In situ 
hybridization on whole embryos was performed using DIG-labeled probes as previously 
described (Kanzler et al., 1998). Skeletal analyses were performed using the Alcian 
blue/alizarin red staining method as previously described (Mallo and Brändlin, 1997). For 
histological analyses, embryos were fixed in Bouin’s fixative and embedded in paraffin. 
10 µm thick sections were then stained with haematoxylin/eosin using standard 
histological methods. Identification of β-galactosidase activity was performed by X-gal 
staining according to Carvajal et al. (2001). 
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FIGURE LEGENDS 
 
Figure 1. Posterior displacement of the trunk to tail transition in Gdf11 mutant 
embryos. Different aspects of the trunk to tail transition were compared between wild 
type (A,D,F,H,J,L,N) or Gdf11-/- (B, E, G, I, K, M, O) embryos. A, B. Gross morphology 
of wild type and Gdf11 mutant embryos at E11.5. The smaller size of the hindlimb is 
evident in the mutants. The size (in somite units) of the interlimb area is indicated. C. 
Estimation of the embryonic age of E10.5 and E11.5 wild type and Gdf11-/- embryos 
according to the size of the hindlimbs. Results are shown as the mean ± SEM. ***, 
P<0.0001. D,E. Estimation of the position of hindlimb induction (evidenced by Tbx4, 
arrows) with respect to the somite number (evidenced by Uncx4.1). F,G. Endodermal 
component of the cloaca in E11.5 embryos, labeled by Shh (arrow). H,I. Cloacal/urethral 
epithelium in E11.5 embryos, revealed by Fgf8 (arrow). Gdf11 mutant embryos exhibited 
increased expression of Fgf8 in the tail bud (arrowhead). J,K. Identification of the 
mesodermal component of the developing cloaca at E10.5 by Isl1 expression (arrow). 
The asterisk indicates the position of the hindlimb. L,M. Extended formation of 
intermediate mesoderm, identified by Pax2, until the posterior part of the hindlimb 
(asterisk) in E10.5 embryos (indicated by the arrows). N,O. Identification of the visceral 
lateral mesoderm by Wnt2 expression. The brackets show the expression area close to the 
hindlimb. 
 
Figure 2. Anteriorization of the trunk to tail transition in Cdx2P-Alk5CA transgenic 
embryos. Analysis of different aspects of AP patterning in E10.5 wild type (A,C,E, 
G,I,K) and Cdx2P-Alk5CA (B,D,F,H,J,L) embryos. A,B. Labeling of the lateral mesoderm 
and hindlimbs with Hand2. .C,D. Labeling of the visceral lateral mesoderm (arrow) with 
Wnt2. E,F. Labeling of the mesodermal component of the cloaca (arrow) with Isl1. G,H. 
Labeling of the endodermal component of the cloaca (arrow) with Shh. I,J. Expression of 
Hoxa9. Arrows mark the anterior limit of expression in the neural tube. K,L. Expression 
of Hoxc10. Arrows mark the anterior limit of expression and the red arrowhead indicates 
ectopic expression in the neural tube of the transgenic embryo. In all panels the position 
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of the hindlimb is indicated with an asterisk except for panel H, where it is indicated with 
a bracket. 
 
Figure 3. Abnormal posterior growth zone in Gdf11 mutant embryos. Posterior 
growth zone was analyzed in wild type (A,C,E,I,K,M,O) and Gdf11 mutant (B,D,F,G,H, 
J,L,N,P) embryos. T expression was analyzed at E9.5 (A,B), E10.5 (C,D,G,H), and E11.5 
(E,F). The arrows indicate the extended anterior expression through the ventral part of the 
tail. The arrowhead in F indicates the tip of the tail. Cdx2 (I,J), Fgf8 (K,L), and Wnt3a 
(M,N) expression was analyzed at E10.5. The arrows indicate the extended anterior 
expression through the ventral part of the tail. The arrowheads in K and L indicate the tail 
bud tip, with upregulation of Fgf8 in the Gdf11 mutant. G. Effect of treatment of Gdf11 
mutants with the RA inhibitor AGN193109 during the trunk to tail transition on the 
progenitors at E10.5, evaluated by expression of T. H. Effect of treatment of Gdf11 
mutants with RA during the trunk to tail transition on the progenitors at E11.5 evaluated 
by expression of T. The arrow indicates the ventral ectopic domain and the arrowhead the 
position of the tail tip. O,P. Comparison of Cyp26a1 expression in wild type (O) and 
Gdf11 mutant (P) embryos at equivalent relevant stages of the trunk to tail transition (21 
somites for wild type, 27 somites for Gdf11-/- embryos). 
 
Figure 4. Effect of Hoxb9 on the trunk to tail transition. A,B. The position of the 
hindlimb was analyzed in E10.5 wild type (A) and Cdx2P-Hoxb9 (B) embryos, labeling 
the somites with Uncx4.1 and the hindlimb with Tbx4. C,D. Skeletal analysis of wild type 
(C) and Cdx2P-Hoxb9 (D) fetuses at E18.5. Indicated are the number of the last rib-
containing vertebra (T13), the number of lumbar vertebra and the position of the first 
sacra vertebra (arrow). 
 
Figure 5. The role of Isl1 in the trunk to tail transition. A, B. Shh expression in the 
hindlimb buds of E10.5 wild type (A) and Cdx2P-Alk5CA (B) transgenic embryos. 
Expression in the posterior part of the wild type hindlimb (arrow) and along the whole 
AP extension of the distal part of the transgenic hindlimb (line) is indicated. C,D External 
morphology of wild type (C) and Cdx2P-Isl1 transgenics (D) at E18.5. E-H. Truncated 
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phenotype of Cdx2P-Isl1 transgenic embryos at E10.5. E,F. Staining with Uncx4.1 
(somites) and Tbx4 (hindlimb) to show the anteriorization of the hindlimb bud of Cdx2P-
Isl1 transgenic embryos (F) (8 somites from the forelimb bud in this embryo), when 
compared to wild type littermates (E). G,H. In situ hybridization with T. Expression in 
the notochord (N) is observed in both wild type (G) Cdx2P-Isl1 transgenic (H) embryos. 
However, expression in the tail bud (arrowheads) is mostly absent from the Cdx2P-Isl1 
transgenic embryo. The arrow in H indicates the ectopic end of the T expression domain 
next to the hindlimb (indicated with a bracket), which in this embryo is located 6 somites 
posterior to the forelimb bud. I,J. Skeletal staining of of wild type (I) and Cdx2P-Isl1 
transgenics (J) at E18.5. K-O. Sagittal sections of E18.5 wild type (K) and Cdx2P-Isl1 
transgenics (I-O) showing: K, the external genitalia (G), together with the independent 
uretra (UT) and rectum (R) in wild type embryos; L, the external genitalia (G) and a 
combined rectum/urethra (R/UT) in Cdx2P-Isl1 transgenics; M, the convergence of the 
urethra (UT) and rectum (R) into a single distal tube (arrow) in the transgenics; N, the 
truncation in the neural tube (NT) in the transgenics; O, the presence of kidneys in the 
transgenics. UR: ureter; BL: urinary bladder. 
 
Figure 6. Isl1 expression requires Smad activity. A. Sequence of the CR2 enhancer of 
the Isl1 gene. The Fox binding sites are highlighted in green and the Smad binding sites 
in red and in orange (the palindromic site). B. Schematic representation of the reporter 
constructs for the Isl1-CR2 enhancer. The Fox and Smad binding sites are represented by 
green diamonds and blue circles, respectively. In the mutant constructs, the Smad binding 
sites were mutated. C. Isl1 expression in the posterior part of the embryo shortly after the 
trunk to tail transition. D. β-galactosidase expression in Isl1-βgal transgenics in E9.25 
embryos. E. Absent β-galactosidase expression in Isl1-βgal-ΔS transgenics in E9.25 
embryos. Numbers of positive cases in relation to the total number of harvested embryos 
is indicated between brackets. 
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SUPPLEMENTARY FIGURES 
 
 
 
 
Figure S1 (related to Fig.1). Phenotypes of Gdf11 mutant embryos. A, B. Hindlimb 
skeletons of E18.5 wild-type (A) and Gdf11 mutant (B) fetuses. C-F. Raldh2 expression 
in wild-type (C, E) and Gdf11 mutant (D, F) embryos at E9.5 (C, D) or E11.5 (E, F). The 
arrows indicate expression in the intermediate mesoderm and the arrowheads indicate the 
mesodermal component of the developing cloaca. 
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Figure S2 (related to Fig. 2). A-C. Activity of the Cdx2P enhancer. The activity of the 
enhancer was estimated by crossing a Cdx2P-creERT transgenic line with the reporter 
ROSA26R. Cre activity was induced by tamoxifen administration at E6.5 and E7.5 (A,B) 
or at E9.5 (C). The embryos were recovered and stained for β-galactosidase at E9.5 (A, 
B) or E10.5 (C). Recombination was first detected only at the level of the forelimb 
despite tamoxifen having been administered during formation of more anterior embryonic 
areas, suggesting lack of Cdx2P activity anterior to the forelimbs. Caudal to this region, 
all neural and mesodermal tissues were labeled. A and B show two different views of the 
same embryo to facilitate observation of both expression in the caudal embryo and the 
position of the forelimb bud (black arrow), which is mostly negative for β-galactosidase. 
Tamoxifen injection at E9.5 was used to discern to which extent the wide staining 
observed in A and B resulted from Cdx2P-driven activity in neural and mesodermal 
derivatives or from recombination in the progenitors of the epiblast that was then stably 
transmitted to their derived tissues. The observation that under this induction condition 
activation was achieved only in more caudal embryonic areas, which coincided with the 
area of axial extension after tamoxifen injection, supports the conclusion of activity being 
mainly in the progenitors. The red arrow indicates the position of the hindlimb, which 
contains just a few labeled cells. D,E. Axial truncation in Cdx2P-Alk5CA embryos. 
Wild type (D) and Cdx2P-Alk5CA transgenic (E) embryos stained for Fgf8 expression. 
The transgenic embryo was fairly normal up to the forelimb bud (arrow), but failed to 
extend further than this axial level. 
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Figure S3 (related to Fig. 3). Tail phenotypes of Gdf11 mutant embryos. A, B. Gross 
morphology of the tail of a wild type (A) and a Gdf11 mutant (B) embryo at E11.5. The 
mutant embryo has a split tail. C, D. T expression in E11.5 wild type (C) and Gdf11 
mutant (D) embryo with a split tail. The arrowheads indicate the tips of the split tails and 
the arrow an ectopic ventral expression domain next to the hindlimbs. E, F. Cdx2 
expression in E11.5 wild-type (E) and Gdf11 mutant (F) embryos. G, H. Wnt3a 
expression in E11.5 wild-type (G) and Gdf11 mutant (H) embryos. I, J. Sagittal sections 
showing the posterior region of a wild type (I) and a Gdf11 mutant (J) embryo. The arrow 
indicates the ectopic neural tissue ventral to the vertebral column. V: vertebral column; 
NT: neural tube; G: genital tuberculum. 
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Figure S4 (related to Fig. 4). Analysis of Hox gene expression in Gdf11 mutant 
embryos. Wild-type (A, C, E) and Gdf11 mutant (B, D, F) embryos were analyzed with 
Hoxc8 (A, B), Hoxa9 (C, D), and Hoxc10 (E, F) at E10.5. The anterior expression border 
of Hoxc8 in Gdf11 mutants is similar to that in wild type embryos. The anterior 
expression borders for Hoxa9 and Hoxc10 are posteriorly displaced in Gdf11 mutant 
embryos following the relocation of the hindlimb. 
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Table	  S1	  (related	  to	  Fig.	  4).	  Summary	  of	  transgenics	  obtained	  over-­‐expressing	  Hox	  genes	  in	  the	  axial	  progenitors.	  	  
Construct	   Number	  of	  transgenics&	  E10.5	   E18.5	   total	  
Cdx2P-­‐Hoxb9	   10	  (2)*	   7	  (3)*	   17	  (5)*	  
Cdx2P-­‐Hoxa10	   10	  (0)	   6	  (0)	   16	  (0)	  
Cdx2P-­‐Hoxc10	   6	  (0)	   -­‐	   6	  (0)	  
Cdx2P-­‐Hoxa11	   8	  (0)	   7	  (0)	   15	  (0)	  
Cdx2P-­‐Hoxb9	  +	  Cdx2P-­‐Hoxa10	   9	  (0)	   -­‐	   9	  (0)	  
Cdx2P-­‐Hoxb9	  +	  Cdx2P-­‐Hoxa11	   6	  (0)	   -­‐	   6	  (0)	  	  &	  Indicated	  in	  parenthesis	  is	  the	  number	  of	  transgenics	  in	  which	  we	  observed	  alteration	  in	  the	  hindlimb	  position.	  *	  Anteriorization	  of	  the	  hindlimb	  position	  by	  one	  segment.	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SUPPLEMENTARY METHOD 
 
Analysis of external morphology using hydrochloric carmine staining (based on 
Machado-Silva et al., 1998) 
Embryos were dissected out and fixed overnight in 4% paraformaldehyde (made in PBS) 
at 4ºC. Fixed embryos were then washed twice in PBS containing 0.1% Tween 20 (PBT) 
at room temperature and then brought to 100% methanol through a methanol/PBT series. 
Dehydrated embryos were then incubated in 75% methanol (made in PBT) at room 
temperature before staining overnight with a 2% solution of carmine powder in 70% 
ethanol/2% chlorine acid in the dark at room temperature with constant shaking. Embryos 
were then washed quickly in 5% acid ethanol and dehydrated again in 100% methanol. 
Images were taken at this stage with a Zeiss StereroLumar scope. In addition, embryos 
were subsequently transferred to methyl salicylate through a graded series of methyl 
salicylate in methanol and imaged by laser scanning confocal microscopy (Zeiss LSM-
510 Meta). 
 
